MaxLinear, Inc. Announces Third Quarter 2024 Financial Results
-
Net revenue of
$81.1 million in Q3, GAAP gross margin of 54.4% and non-GAAP gross margin of 58.7%
Third Quarter Financial Highlights
GAAP basis:
-
Net revenue was
$81.1 million , down 12% sequentially anddown 40% year-over-year. - GAAP gross margin was 54.4%, compared to 54.6% in the prior quarter, and 54.6% in the year-ago quarter.
-
GAAP operating expenses were
$110.8 million in the third quarter 2024, or 137% of net revenue, compared to$91.0 million in the prior quarter, or 99% of net revenue, and$91.8 million in the year-ago quarter, or 68% of net revenue. - GAAP loss from operations was 82% of net revenue, compared to loss from operations of 44% of net revenue in the prior quarter, and loss from operations of 13% of net revenue in the year-ago quarter.
-
Net cash flow used in operating activities was
$30.7 million , compared to net cash flow used in operating activities of$2.7 million in the prior quarter, and net cash flow used in operating activities of$12.8 million in the year-ago quarter. -
GAAP diluted loss per share was
$0.90 , compared to diluted loss per share of$0.47 in the prior quarter, and diluted loss per share of$0.49 in the year-ago quarter.
Non-GAAP basis:
- Non-GAAP gross margin was 58.7%. This compares to 60.2% in the prior quarter, and 60.8% in the year-ago quarter.
-
Non-GAAP operating expenses were
$72.8 million , or 90% of net revenue, compared to$74.8 million or 81% of net revenue in the prior quarter, and$75.1 million or 55% of net revenue in the year-ago quarter. - Non-GAAP loss from operations was 31% of net revenue, compared to loss of 21% in the prior quarter, and income of 5% in the year-ago quarter.
-
Non-GAAP diluted loss per share was
$0.36 , compared to loss of$0.25 in the prior quarter, and earnings of$0.02 in the year-ago quarter.
Management Commentary
“We are pleased to see encouraging signs of recovery in our business, including another quarter of improvement in customer orders and continued progress in new product traction,” said
Fourth Quarter 2024 Business Outlook
The company expects net revenue in the fourth quarter of 2024 to be approximately
- GAAP gross margin of approximately 54.0% to 57.0%;
- Non-GAAP gross margin of approximately 57.5% to 60.5%;
-
GAAP operating expenses of approximately
$88 million to$94 million ; -
Non-GAAP operating expenses of approximately
$58 million to$64 million ; -
GAAP and non-GAAP interest and other expense of approximately
$1.0 million to$2.5 million each; and - GAAP and non-GAAP diluted share count of approximately 84.5 million each.
Webcast and Conference Call
Cautionary Note Concerning Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include, among others, statements concerning our future financial performance (including our current guidance for fourth quarter 2024
net revenue, and GAAP and non-GAAP amounts for each of the following: gross margins, operating expenses, interest and other expenses, and diluted share counts); our potential growth and revenue opportunities; market trends; settlement of bonus awards for our 2024 performance period; and statements by our Chairman and CEO. These forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to be materially different from any future results expressed or implied by the forward-looking statements and our future financial performance and operating results forecasts generally. Forward-looking statements are based on management’s current, preliminary expectations and are subject to various risks and uncertainties. In particular, our future operating results are substantially dependent on our assumptions about market trends and conditions. Additional risks and uncertainties affecting our business, future operating results and financial condition include, without limitation; risks relating to our terminated merger with
In addition to these risks and uncertainties, investors should review the risks and uncertainties contained in our filings with the
Use of Non-GAAP Financial Measures
To supplement our unaudited consolidated financial statements presented on a basis consistent with GAAP, we disclose certain non-GAAP financial measures, including non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating expenses as a percentage of net revenue, non-GAAP income (loss) from operations, non-GAAP income (loss) from operations as percentage of revenue, non-GAAP interest and other income (expense), non-GAAP diluted earnings (loss) per share, and non-GAAP diluted share count. These supplemental measures exclude the effects of (i) stock-based compensation expense; (ii) accruals related to our performance-based bonus plan for 2024, which we intend to settle in shares of our common stock; (iii) accruals related to our performance-based bonus plan for 2023, which we settled in shares of common stock in
We believe that non-GAAP financial measures can provide useful information to both management and investors by excluding certain non-cash and other one-time expenses that we believe are not indicative of our core operating results. Among other uses, our management uses non-GAAP measures to compare our performance relative to forecasts and strategic plans and to benchmark our performance externally against competitors. In addition, management’s incentive compensation will be determined in part using these non-GAAP measures because we believe non-GAAP measures better reflect our core operating performance.
The following are explanations of each type of adjustment that we incorporate into non-GAAP financial measures:
Stock-based compensation expense relates to equity incentive awards granted to our employees, directors, and consultants. Our equity incentive plans are important components of our employee incentive compensation arrangements and are reflected as expenses in our GAAP results. Stock-based compensation expense has been and will continue to be a significant recurring expense for
Performance-based equity consists of accruals related to our executive and non-executive bonus programs, and have been excluded from our non-GAAP net income or loss for all periods reported. Bonus payments for the 2023 performance periods were settled through the issuance of shares of common stock under our equity incentive plans in
Expenses incurred in relation to acquisitions include amortization of purchased intangible assets, acquisition and integration costs primarily consisting of professional and consulting fees, including costs incurred related to the termination of the previously pending (now terminated) merger with
Research and development funded by others represents proceeds received under contracts for jointly funded R&D projects to develop technology that may be commercialized into a product in the future. Initially such proceeds may not yet be recognized in GAAP results if, pursuant to contract terms, the Company may be required to repay all or a portion of the funds provided by the other party under certain conditions. Management believes it is not probable that it will trigger such conditions. Once such conditions have been resolved, the proceeds are recognized in GAAP results, and accordingly, reversed from non-GAAP results.
Impairment losses are related to abandonment of acquired or purchased intangible assets.
Restructuring charges incurred are related to our restructuring plans which eliminate redundancies and primarily include severance and restructuring costs related to impairment of leased right-of-use assets or from exiting certain facilities.
Other expense also includes losses from impairment of privately held investments.
Income tax benefits and expense adjustments are those that do not affect cash income taxes payable.
Reconciliations of non-GAAP measures for the historic periods disclosed in this press release appear below. Because of the inherent uncertainty associated with our ability to project future charges, we are also unable to predict their probable significance, particularly related to stock-based compensation and its related tax effects as well as potential impairments, a quantitative reconciliation is not available without unreasonable efforts and accordingly, in reliance on the exception provided by Item 10(e)(1)(i)(B) of Regulation S-K, we have not provided a reconciliation for non-GAAP guidance provided for the fourth quarter 2024.
About
MXL is MaxLinear’s registered trademark. Other trademarks appearing herein are the property of their respective owners.
|
UNAUDITED GAAP CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except per share data) |
|||||||||||
|
|
Three Months Ended |
||||||||||
|
|
|
|
|
|
|
||||||
|
Net revenue |
$ |
81,102 |
|
|
$ |
91,990 |
|
|
$ |
135,530 |
|
|
Cost of net revenue |
|
37,022 |
|
|
|
41,804 |
|
|
|
61,586 |
|
|
Gross profit |
|
44,080 |
|
|
|
50,186 |
|
|
|
73,944 |
|
|
Operating expenses: |
|
|
|
|
|
||||||
|
Research and development |
|
52,604 |
|
|
|
56,541 |
|
|
|
66,306 |
|
|
Selling, general and administrative |
|
30,154 |
|
|
|
33,600 |
|
|
|
25,402 |
|
|
Impairment losses |
|
1,237 |
|
|
|
— |
|
|
|
— |
|
|
Restructuring charges |
|
26,828 |
|
|
|
865 |
|
|
|
54 |
|
|
Total operating expenses |
|
110,823 |
|
|
|
91,006 |
|
|
|
91,762 |
|
|
Loss from operations |
|
(66,743 |
) |
|
|
(40,820 |
) |
|
|
(17,818 |
) |
|
Interest income |
|
1,653 |
|
|
|
1,871 |
|
|
|
1,736 |
|
|
Interest expense |
|
(2,655 |
) |
|
|
(2,706 |
) |
|
|
(2,715 |
) |
|
Other income (expense), net |
|
(14,753 |
) |
|
|
329 |
|
|
|
(22,721 |
) |
|
Total other income (expense), net |
|
(15,755 |
) |
|
|
(506 |
) |
|
|
(23,700 |
) |
|
Loss before income taxes |
|
(82,498 |
) |
|
|
(41,326 |
) |
|
|
(41,518 |
) |
|
Income tax benefit |
|
(6,713 |
) |
|
|
(2,060 |
) |
|
|
(1,689 |
) |
|
Net loss |
$ |
(75,785 |
) |
|
$ |
(39,266 |
) |
|
$ |
(39,829 |
) |
|
Net loss per share: |
|
|
|
|
|
||||||
|
Basic |
$ |
(0.90 |
) |
|
$ |
(0.47 |
) |
|
$ |
(0.49 |
) |
|
Diluted |
$ |
(0.90 |
) |
|
$ |
(0.47 |
) |
|
$ |
(0.49 |
) |
|
Shares used to compute net loss per share: |
|
|
|
|
|
||||||
|
Basic |
|
84,074 |
|
|
|
83,477 |
|
|
|
81,249 |
|
|
Diluted |
|
84,074 |
|
|
|
83,477 |
|
|
|
81,249 |
|
|
UNAUDITED GAAP CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except per share data) |
||||||||
|
|
|
|
|
|
||||
|
|
|
Nine Months Ended |
||||||
|
|
|
|
|
|
||||
|
Net revenue |
|
$ |
268,361 |
|
|
$ |
567,910 |
|
|
Cost of net revenue |
|
|
124,827 |
|
|
|
250,786 |
|
|
Gross profit |
|
|
143,534 |
|
|
|
317,124 |
|
|
Operating expenses: |
|
|
|
|
||||
|
Research and development |
|
|
173,911 |
|
|
|
204,254 |
|
|
Selling, general and administrative |
|
|
100,242 |
|
|
|
97,772 |
|
|
Impairment losses |
|
|
1,237 |
|
|
|
2,438 |
|
|
Restructuring charges |
|
|
50,323 |
|
|
|
9,138 |
|
|
Total operating expenses |
|
|
325,713 |
|
|
|
313,602 |
|
|
Income (loss) from operations |
|
|
(182,179 |
) |
|
|
3,522 |
|
|
Interest income |
|
|
5,346 |
|
|
|
4,272 |
|
|
Interest expense |
|
|
(8,072 |
) |
|
|
(7,793 |
) |
|
Other income (expense), net |
|
|
(12,990 |
) |
|
|
(21,180 |
) |
|
Total other income (expense), net |
|
|
(15,716 |
) |
|
|
(24,701 |
) |
|
Loss before income taxes |
|
|
(197,895 |
) |
|
|
(21,179 |
) |
|
Income tax provision (benefit) |
|
|
(10,535 |
) |
|
|
13,468 |
|
|
Net loss |
|
$ |
(187,360 |
) |
|
$ |
(34,647 |
) |
|
Net loss per share: |
|
|
|
|
||||
|
Basic |
|
$ |
(2.25 |
) |
|
$ |
(0.43 |
) |
|
Diluted |
|
$ |
(2.25 |
) |
|
$ |
(0.43 |
) |
|
Shares used to compute net loss per share: |
|
|
|
|
||||
|
Basic |
|
|
83,303 |
|
|
|
80,395 |
|
|
Diluted |
|
|
83,303 |
|
|
|
80,395 |
|
|
|
|
|
|
|
||||
|
UNAUDITED GAAP CONSOLIDATED STATEMENTS OF CASH FLOWS (in thousands) |
||||||||||||
|
|
Three Months Ended |
|||||||||||
|
|
|
|
|
|||||||||
|
Operating Activities |
|
|
|
|||||||||
|
Net loss |
$ |
(75,785 |
) |
$ |
(39,266 |
) |
$ |
(39,829 |
) |
|||
|
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
|||||||||
|
Amortization and depreciation |
|
12,142 |
|
|
13,600 |
|
|
17,014 |
|
|||
|
Impairment of intangible assets |
|
1,237 |
|
|
— |
|
|
— |
|
|||
|
Impairment of investments and other assets |
|
14,000 |
|
|
— |
|
|
— |
|
|||
|
Amortization of debt issuance costs and accretion of discount on debt and leases |
|
637 |
|
|
665 |
|
|
685 |
|
|||
|
Stock-based compensation |
|
12,788 |
|
|
17,359 |
|
|
5,118 |
|
|||
|
Deferred income taxes |
|
(8,320 |
) |
|
(2,053 |
) |
|
(2,384 |
) |
|||
|
Loss on disposal of property and equipment |
|
623 |
|
|
55 |
|
|
16 |
|
|||
|
Unrealized holding loss on investments |
|
— |
|
|
— |
|
|
5,876 |
|
|||
|
Impairment of leased right-of-use assets |
|
677 |
|
|
700 |
|
|
— |
|
|||
|
(Gain) loss on extinguishment of lease liabilities |
|
(1 |
) |
|
16 |
|
|
— |
|
|||
|
Gain on settlement of pension |
|
— |
|
|
— |
|
|
(1,008 |
) |
|||
|
(Gain) loss on foreign currency and other |
|
2,339 |
|
|
(398 |
) |
|
(13 |
) |
|||
|
Excess tax (benefits) deficiencies on stock based awards |
|
(1,469 |
) |
|
(152 |
) |
|
769 |
|
|||
|
Changes in operating assets and liabilities: |
|
|
|
|||||||||
|
Accounts receivable, net |
|
37,010 |
|
|
41,290 |
|
|
(2,398 |
) |
|||
|
Inventory |
|
(1,325 |
) |
|
1,387 |
|
|
11,210 |
|
|||
|
Prepaid expenses and other assets |
|
(7,852 |
) |
|
1,281 |
|
|
(4,563 |
) |
|||
|
Accounts payable, accrued expenses and other current liabilities |
|
(3,770 |
) |
|
(24,280 |
) |
|
9,347 |
|
|||
|
Accrued compensation |
|
159 |
|
|
(5,855 |
) |
|
4,914 |
|
|||
|
Accrued price protection liability |
|
(17,158 |
) |
|
(3,603 |
) |
|
(11,995 |
) |
|||
|
Lease liabilities |
|
(2,761 |
) |
|
(2,540 |
) |
|
(2,882 |
) |
|||
|
Other long-term liabilities |
|
6,098 |
|
|
(902 |
) |
|
(2,669 |
) |
|||
|
Net cash used in operating activities |
|
(30,731 |
) |
|
(2,696 |
) |
|
(12,792 |
) |
|||
|
Investing Activities |
|
|
|
|||||||||
|
Purchases of property and equipment |
|
(4,132 |
) |
|
(3,013 |
) |
|
(1,927 |
) |
|||
|
Purchases of intangible assets |
|
(1,818 |
) |
|
(2,775 |
) |
|
(674 |
) |
|||
|
Net cash used in investing activities |
|
(5,950 |
) |
|
(5,788 |
) |
|
(2,601 |
) |
|||
|
Financing Activities |
|
|
|
|||||||||
|
Payment of debt commitment fees |
|
— |
|
|
— |
|
|
(18,325 |
) |
|||
|
Net proceeds from issuance of common stock |
|
— |
|
|
1,579 |
|
|
92 |
|
|||
|
Minimum tax withholding paid on behalf of employees for restricted stock units |
|
(58 |
) |
|
447 |
|
|
(3,232 |
) |
|||
|
Net cash provided by (used in) financing activities |
|
(58 |
) |
|
2,026 |
|
|
(21,465 |
) |
|||
|
Effect of exchange rate changes on cash, cash equivalents and restricted cash |
|
94 |
|
|
(335 |
) |
|
(633 |
) |
|||
|
Decrease in cash, cash equivalents and restricted cash |
|
(36,645 |
) |
|
(6,793 |
) |
|
(37,491 |
) |
|||
|
Cash, cash equivalents and restricted cash at beginning of period |
|
186,137 |
|
|
192,930 |
|
|
225,643 |
|
|||
|
Cash, cash equivalents and restricted cash at end of period |
$ |
149,492 |
|
$ |
186,137 |
|
$ |
188,152 |
|
|||
|
UNAUDITED GAAP CONSOLIDATED STATEMENTS OF CASH FLOWS (in thousands) |
||||||||
|
|
|
|
|
|
||||
|
|
|
Nine Months Ended |
||||||
|
|
|
|
|
|
||||
|
Operating Activities |
|
|
|
|
||||
|
Net loss |
|
$ |
(187,360 |
) |
|
$ |
(34,647 |
) |
|
Adjustments to reconcile net loss to cash provided by (used in) operating activities: |
|
|
|
|
||||
|
Amortization and depreciation |
|
|
42,426 |
|
|
|
54,923 |
|
|
Impairment of intangible assets |
|
|
1,237 |
|
|
|
2,438 |
|
|
Impairment of investments and other assets |
|
|
14,000 |
|
|
|
— |
|
|
Amortization of debt issuance costs and accretion of discount on debt and leases |
|
|
1,990 |
|
|
|
1,858 |
|
|
Stock-based compensation |
|
|
47,208 |
|
|
|
38,763 |
|
|
Deferred income taxes |
|
|
(13,058 |
) |
|
|
6,502 |
|
|
Loss on disposal of property and equipment |
|
|
1,068 |
|
|
|
2,057 |
|
|
Unrealized holding loss on investments |
|
|
— |
|
|
|
3,917 |
|
|
Impairment of leased right-of-use assets |
|
|
3,415 |
|
|
|
— |
|
|
Gain on settlement of pension |
|
|
— |
|
|
|
(1,008 |
) |
|
Gain on extinguishment of lease liabilities |
|
|
(554 |
) |
|
|
— |
|
|
Loss on foreign currency |
|
|
973 |
|
|
|
140 |
|
|
Excess tax benefits on stock-based awards |
|
|
(2,988 |
) |
|
|
(529 |
) |
|
Changes in operating assets and liabilities: |
|
|
|
|
||||
|
Accounts receivable, net |
|
|
122,689 |
|
|
|
13,769 |
|
|
Inventory |
|
|
3,845 |
|
|
|
45,602 |
|
|
Prepaid expenses and other assets |
|
|
(8,615 |
) |
|
|
(10,215 |
) |
|
Accounts payable, accrued expenses and other current liabilities |
|
|
(16,041 |
) |
|
|
(17,917 |
) |
|
Accrued compensation |
|
|
3,011 |
|
|
|
8,776 |
|
|
Accrued price protection liability |
|
|
(27,212 |
) |
|
|
(45,036 |
) |
|
Lease liabilities |
|
|
(7,806 |
) |
|
|
(8,891 |
) |
|
Other long-term liabilities |
|
|
4,315 |
|
|
|
(557 |
) |
|
Net cash provided by (used in) operating activities |
|
|
(17,457 |
) |
|
|
59,945 |
|
|
Investing Activities |
|
|
|
|
||||
|
Purchases of property and equipment |
|
|
(15,487 |
) |
|
|
(12,180 |
) |
|
Purchases of intangible assets |
|
|
(4,961 |
) |
|
|
(6,198 |
) |
|
Cash used in acquisitions, net of cash acquired |
|
|
— |
|
|
|
(12,384 |
) |
|
Net cash used in investing activities |
|
|
(20,448 |
) |
|
|
(30,762 |
) |
|
Financing Activities |
|
|
|
|
||||
|
Payment of debt commitment fees |
|
|
— |
|
|
|
(18,325 |
) |
|
Net proceeds from issuance of common stock |
|
|
1,579 |
|
|
|
3,168 |
|
|
Minimum tax withholding paid on behalf of employees for restricted stock units |
|
|
(1,714 |
) |
|
|
(12,370 |
) |
|
Net cash used in financing activities |
|
|
(135 |
) |
|
|
(27,527 |
) |
|
Effect of exchange rate changes on cash, cash equivalents and restricted cash |
|
|
(824 |
) |
|
|
(1,861 |
) |
|
Decrease in cash, cash equivalents and restricted cash |
|
|
(38,864 |
) |
|
|
(205 |
) |
|
Cash, cash equivalents and restricted cash at beginning of period |
|
|
188,356 |
|
|
|
188,357 |
|
|
Cash, cash equivalents and restricted cash at end of period |
|
$ |
149,492 |
|
|
$ |
188,152 |
|
|
UNAUDITED GAAP CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands) |
||||||||
|
|
|
|
|
|
|
|||
|
Assets |
|
|
|
|
|
|||
|
Current assets: |
|
|
|
|
|
|||
|
Cash and cash equivalents |
$ |
148,476 |
|
$ |
185,108 |
|
$ |
187,028 |
|
Short-term restricted cash |
|
993 |
|
|
1,006 |
|
|
1,105 |
|
Short-term investments |
|
— |
|
|
— |
|
|
14,612 |
|
Accounts receivable, net |
|
47,930 |
|
|
84,940 |
|
|
158,232 |
|
Inventory |
|
96,063 |
|
|
94,738 |
|
|
114,942 |
|
Prepaid expenses and other current assets |
|
34,798 |
|
|
31,789 |
|
|
32,688 |
|
Total current assets |
|
328,260 |
|
|
397,581 |
|
|
508,607 |
|
Long-term restricted cash |
|
23 |
|
|
23 |
|
|
19 |
|
Property and equipment, net |
|
63,493 |
|
|
65,422 |
|
|
69,484 |
|
Leased right-of-use assets |
|
22,549 |
|
|
24,883 |
|
|
32,647 |
|
Intangible assets, net |
|
58,031 |
|
|
61,786 |
|
|
82,643 |
|
|
|
318,588 |
|
|
318,588 |
|
|
318,456 |
|
Deferred tax assets |
|
82,552 |
|
|
74,228 |
|
|
59,121 |
|
Other long-term assets |
|
21,807 |
|
|
30,686 |
|
|
32,810 |
|
Total assets |
$ |
895,303 |
|
$ |
973,197 |
|
$ |
1,103,787 |
|
|
|
|
|
|
|
|||
|
Liabilities and stockholders’ equity |
|
|
|
|
|
|||
|
Current liabilities |
$ |
168,597 |
|
$ |
190,277 |
|
$ |
232,910 |
|
Long-term lease liabilities |
|
19,433 |
|
|
21,522 |
|
|
28,017 |
|
Long-term debt |
|
122,840 |
|
|
122,684 |
|
|
122,219 |
|
Other long-term liabilities |
|
27,561 |
|
|
21,459 |
|
|
17,964 |
|
Stockholders’ equity |
|
556,872 |
|
|
617,255 |
|
|
702,677 |
|
Total liabilities and stockholders’ equity |
$ |
895,303 |
|
$ |
973,197 |
|
$ |
1,103,787 |
|
UNAUDITED RECONCILIATION OF NON-GAAP ADJUSTMENTS (in thousands, except per share data) |
|||||||||||
|
|
Three Months Ended |
||||||||||
|
|
|
|
|
|
|
||||||
|
GAAP gross profit |
$ |
44,080 |
|
|
$ |
50,186 |
|
|
$ |
73,944 |
|
|
Stock-based compensation |
|
81 |
|
|
|
173 |
|
|
|
170 |
|
|
Performance based equity |
|
(19 |
) |
|
|
(37 |
) |
|
|
19 |
|
|
Amortization of purchased intangible assets |
|
3,498 |
|
|
|
5,089 |
|
|
|
8,332 |
|
|
Non-GAAP gross profit |
|
47,640 |
|
|
|
55,411 |
|
|
|
82,465 |
|
|
|
|
|
|
|
|
||||||
|
GAAP R&D expenses |
|
52,604 |
|
|
|
56,541 |
|
|
|
66,306 |
|
|
Stock-based compensation |
|
(7,423 |
) |
|
|
(10,088 |
) |
|
|
(9,436 |
) |
|
Performance based equity |
|
775 |
|
|
|
1,789 |
|
|
|
(2,288 |
) |
|
Research and development funded by others |
|
3,000 |
|
|
|
— |
|
|
|
(5,500 |
) |
|
Non-GAAP R&D expenses |
|
48,956 |
|
|
|
48,242 |
|
|
|
49,082 |
|
|
|
|
|
|
|
|
||||||
|
GAAP SG&A expenses |
|
30,154 |
|
|
|
33,600 |
|
|
|
25,402 |
|
|
Stock-based compensation |
|
(5,284 |
) |
|
|
(7,097 |
) |
|
|
4,488 |
|
|
Performance based equity |
|
384 |
|
|
|
722 |
|
|
|
(999 |
) |
|
Amortization of purchased intangible assets |
|
(591 |
) |
|
|
(592 |
) |
|
|
(653 |
) |
|
Acquisition and integration costs |
|
(801 |
) |
|
|
(102 |
) |
|
|
(2,172 |
) |
|
Non-GAAP SG&A expenses |
|
23,862 |
|
|
|
26,531 |
|
|
|
26,066 |
|
|
|
|
|
|
|
|
||||||
|
GAAP impairment losses |
|
1,237 |
|
|
|
— |
|
|
|
— |
|
|
Impairment losses |
|
(1,237 |
) |
|
|
— |
|
|
|
— |
|
|
Non-GAAP impairment losses |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
||||||
|
GAAP restructuring expenses |
|
26,828 |
|
|
|
865 |
|
|
|
54 |
|
|
Restructuring charges |
|
(26,828 |
) |
|
|
(865 |
) |
|
|
(54 |
) |
|
Non-GAAP restructuring expenses |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
||||||
|
GAAP loss from operations |
|
(66,743 |
) |
|
|
(40,820 |
) |
|
|
(17,818 |
) |
|
Total non-GAAP adjustments |
|
41,565 |
|
|
|
21,458 |
|
|
|
25,135 |
|
|
Non-GAAP income (loss) from operations |
|
(25,178 |
) |
|
|
(19,362 |
) |
|
|
7,317 |
|
|
|
|
|
|
|
|
||||||
|
GAAP interest and other income (expense), net |
|
(15,755 |
) |
|
|
(506 |
) |
|
|
(23,700 |
) |
|
Non-recurring interest and other income (expense), net |
|
11,769 |
|
|
|
65 |
|
|
|
18,395 |
|
|
Non-GAAP interest and other income (expense), net |
|
(3,986 |
) |
|
|
(441 |
) |
|
|
(5,305 |
) |
|
|
|
|
|
|
|
||||||
|
GAAP loss before income taxes |
|
(82,498 |
) |
|
|
(41,326 |
) |
|
|
(41,518 |
) |
|
Total non-GAAP adjustments |
|
53,334 |
|
|
|
21,523 |
|
|
|
43,530 |
|
|
Non-GAAP income (loss) before income taxes |
|
(29,164 |
) |
|
|
(19,803 |
) |
|
|
2,012 |
|
|
|
|
|
|
|
|
||||||
|
GAAP income tax benefit |
|
(6,713 |
) |
|
|
(2,060 |
) |
|
|
(1,689 |
) |
|
Adjustment for non-cash tax benefits/expenses |
|
7,568 |
|
|
|
3,205 |
|
|
|
1,891 |
|
|
Non-GAAP income tax provision |
|
855 |
|
|
|
1,145 |
|
|
|
202 |
|
|
|
|
|
|
|
|
||||||
|
GAAP net loss |
|
(75,785 |
) |
|
|
(39,266 |
) |
|
|
(39,829 |
) |
|
Total non-GAAP adjustments before income taxes |
|
53,334 |
|
|
|
21,523 |
|
|
|
43,530 |
|
|
Less: total tax adjustments |
|
7,568 |
|
|
|
3,205 |
|
|
|
1,891 |
|
|
Non-GAAP net income (loss) |
$ |
(30,019 |
) |
|
$ |
(20,948 |
) |
|
$ |
1,810 |
|
|
|
|
|
|
|
|
||||||
|
Shares used in computing GAAP and non-GAAP basic net income (loss) per share |
|
84,074 |
|
|
|
83,477 |
|
|
|
81,249 |
|
|
Shares used in computing GAAP diluted net loss per share |
|
84,074 |
|
|
|
83,477 |
|
|
|
81,249 |
|
|
Dilutive common stock equivalents |
|
— |
|
|
|
— |
|
|
|
719 |
|
|
Shares used in computing non-GAAP diluted net income (loss) per share |
|
84,074 |
|
|
|
83,477 |
|
|
|
81,968 |
|
|
Non-GAAP basic net income (loss) per share |
$ |
(0.36 |
) |
|
$ |
(0.25 |
) |
|
$ |
0.02 |
|
|
Non-GAAP diluted net income (loss) per share |
$ |
(0.36 |
) |
|
$ |
(0.25 |
) |
|
$ |
0.02 |
|
|
UNAUDITED RECONCILIATION OF NON-GAAP ADJUSTMENTS (in thousands, except per share data) |
|||||||
|
|
|
|
|
||||
|
|
Nine months ended |
||||||
|
|
|
|
|
||||
|
GAAP gross profit |
$ |
143,534 |
|
|
$ |
317,124 |
|
|
Stock-based compensation |
|
435 |
|
|
|
626 |
|
|
Performance based equity |
|
16 |
|
|
|
94 |
|
|
Amortization of purchased intangible assets |
|
16,808 |
|
|
|
26,770 |
|
|
Non-GAAP gross profit |
|
160,793 |
|
|
|
344,614 |
|
|
|
|
|
|
||||
|
GAAP R&D expenses |
|
173,911 |
|
|
|
204,254 |
|
|
Stock-based compensation |
|
(27,952 |
) |
|
|
(33,128 |
) |
|
Performance based equity |
|
(2,365 |
) |
|
|
(5,650 |
) |
|
Research and development funded by others |
|
2,000 |
|
|
|
(7,500 |
) |
|
Non-GAAP R&D expenses |
|
145,594 |
|
|
|
157,976 |
|
|
|
|
|
|
||||
|
GAAP SG&A expenses |
|
100,242 |
|
|
|
97,772 |
|
|
Stock-based compensation |
|
(18,820 |
) |
|
|
(5,009 |
) |
|
Performance based equity |
|
(1,321 |
) |
|
|
(2,550 |
) |
|
Amortization of purchased intangible assets |
|
(1,774 |
) |
|
|
(2,290 |
) |
|
Acquisition and integration costs |
|
(1,567 |
) |
|
|
(7,487 |
) |
|
Non-GAAP SG&A expenses |
|
76,760 |
|
|
|
80,436 |
|
|
|
|
|
|
||||
|
GAAP impairment losses |
|
1,237 |
|
|
|
2,438 |
|
|
Impairment losses |
|
(1,237 |
) |
|
|
(2,438 |
) |
|
Non-GAAP impairment losses |
|
— |
|
|
|
— |
|
|
|
|
|
|
||||
|
GAAP restructuring expenses |
|
50,323 |
|
|
|
9,138 |
|
|
Restructuring charges |
|
(50,323 |
) |
|
|
(9,138 |
) |
|
Non-GAAP restructuring expenses |
|
— |
|
|
|
— |
|
|
|
|
|
|
||||
|
GAAP income (loss) from operations |
|
(182,179 |
) |
|
|
3,522 |
|
|
Total non-GAAP adjustments |
|
120,618 |
|
|
|
102,680 |
|
|
Non-GAAP income (loss) from operations |
|
(61,561 |
) |
|
|
106,202 |
|
|
|
|
|
|
||||
|
GAAP interest and other income (expense), net |
|
(15,716 |
) |
|
|
(24,701 |
) |
|
Non-recurring interest and other income (expense), net |
|
11,907 |
|
|
|
18,574 |
|
|
Non-GAAP interest and other income (expense), net |
|
(3,809 |
) |
|
|
(6,127 |
) |
|
|
|
|
|
||||
|
GAAP loss before income taxes |
|
(197,895 |
) |
|
|
(21,179 |
) |
|
Total non-GAAP adjustments |
|
132,525 |
|
|
|
121,254 |
|
|
Non-GAAP income (loss) before income taxes |
|
(65,370 |
) |
|
|
100,075 |
|
|
|
|
|
|
||||
|
GAAP income tax provision (benefit) |
|
(10,535 |
) |
|
|
13,468 |
|
|
Adjustment for non-cash tax benefits/expenses |
|
13,535 |
|
|
|
(3,460 |
) |
|
Non-GAAP income tax provision |
|
3,000 |
|
|
|
10,008 |
|
|
|
|
|
|
||||
|
GAAP net loss |
|
(187,360 |
) |
|
|
(34,647 |
) |
|
Total non-GAAP adjustments before income taxes |
|
132,525 |
|
|
|
121,254 |
|
|
Less: total tax adjustments |
|
13,535 |
|
|
|
(3,460 |
) |
|
Non-GAAP net income (loss) |
$ |
(68,370 |
) |
|
$ |
90,067 |
|
|
|
|
|
|
||||
|
Shares used in computing GAAP and non-GAAP basic net income (loss) per share |
|
83,303 |
|
|
|
80,395 |
|
|
Shares used in computing GAAP diluted net loss per share |
|
83,303 |
|
|
|
80,395 |
|
|
Dilutive common stock equivalents |
|
— |
|
|
|
1,279 |
|
|
Shares used in computing non-GAAP diluted net income (loss) per share |
|
83,303 |
|
|
|
81,674 |
|
|
Non-GAAP basic net income (loss) per share |
$ |
(0.82 |
) |
|
$ |
1.12 |
|
|
Non-GAAP diluted net income (loss) per share |
$ |
(0.82 |
) |
|
$ |
1.10 |
|
|
UNAUDITED RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
|
||||||||
|
|
Three Months Ended |
|||||||
|
|
|
|
|
|
|
|||
|
GAAP gross margin |
54.4 |
% |
|
54.6 |
% |
|
54.6 |
% |
|
Stock-based compensation |
0.1 |
% |
|
0.2 |
% |
|
0.1 |
% |
|
Performance based equity |
— |
% |
|
— |
% |
|
— |
% |
|
Amortization of purchased intangible assets |
4.3 |
% |
|
5.5 |
% |
|
6.2 |
% |
|
Non-GAAP gross margin |
58.7 |
% |
|
60.2 |
% |
|
60.8 |
% |
|
|
|
|
|
|
|
|||
|
GAAP R&D expenses |
64.9 |
% |
|
61.5 |
% |
|
48.9 |
% |
|
Stock-based compensation |
(9.2 |
)% |
|
(11.0 |
)% |
|
(7.0 |
)% |
|
Performance based equity |
1.0 |
% |
|
1.9 |
% |
|
(1.7 |
)% |
|
Research and development funded by others |
3.7 |
% |
|
— |
% |
|
(4.1 |
)% |
|
Non-GAAP R&D expenses |
60.4 |
% |
|
52.4 |
% |
|
36.2 |
% |
|
|
|
|
|
|
|
|||
|
GAAP SG&A expenses |
37.2 |
% |
|
36.5 |
% |
|
18.7 |
% |
|
Stock-based compensation |
(6.5 |
)% |
|
(7.7 |
)% |
|
3.3 |
% |
|
Performance based equity |
0.5 |
% |
|
0.8 |
% |
|
(0.7 |
)% |
|
Amortization of purchased intangible assets |
(0.7 |
)% |
|
(0.6 |
)% |
|
(0.5 |
)% |
|
Acquisition and integration costs |
(1.0 |
)% |
|
(0.1 |
)% |
|
(1.6 |
)% |
|
Non-GAAP SG&A expenses |
29.4 |
% |
|
28.8 |
% |
|
19.2 |
% |
|
|
|
|
|
|
|
|||
|
GAAP impairment losses |
1.5 |
% |
|
— |
% |
|
— |
% |
|
Impairment losses |
(1.5 |
)% |
|
— |
% |
|
— |
% |
|
Non-GAAP impairment losses |
— |
% |
|
— |
% |
|
— |
% |
|
|
|
|
|
|
|
|||
|
GAAP restructuring expenses |
33.1 |
% |
|
0.9 |
% |
|
— |
% |
|
Restructuring charges |
(33.1 |
)% |
|
(0.9 |
)% |
|
— |
% |
|
Non-GAAP restructuring expenses |
— |
% |
|
— |
% |
|
— |
% |
|
|
|
|
|
|
|
|||
|
GAAP loss from operations |
(82.3 |
)% |
|
(44.4 |
)% |
|
(13.2 |
)% |
|
Total non-GAAP adjustments |
51.3 |
% |
|
23.3 |
% |
|
18.6 |
% |
|
Non-GAAP income (loss) from operations |
(31.0 |
)% |
|
(21.0 |
)% |
|
5.4 |
% |
|
|
|
|
|
|
|
|||
|
GAAP interest and other income (expense), net |
(19.4 |
)% |
|
(0.6 |
)% |
|
(17.5 |
)% |
|
Non-recurring interest and other income (expense), net |
14.5 |
% |
|
0.1 |
% |
|
13.6 |
% |
|
Non-GAAP interest and other income (expense), net |
(4.9 |
)% |
|
(0.5 |
)% |
|
(3.9 |
)% |
|
|
|
|
|
|
|
|||
|
GAAP loss before income taxes |
(101.7 |
)% |
|
(44.9 |
)% |
|
(30.6 |
)% |
|
Total non-GAAP adjustments before income taxes |
65.8 |
% |
|
23.4 |
% |
|
32.1 |
% |
|
Non-GAAP income (loss) before income taxes |
(36.0 |
)% |
|
(21.5 |
)% |
|
1.5 |
% |
|
|
|
|
|
|
|
|||
|
GAAP income tax benefit |
(8.3 |
)% |
|
(2.2 |
)% |
|
(1.3 |
)% |
|
Adjustment for non-cash tax benefits/expenses |
9.3 |
% |
|
3.5 |
% |
|
1.4 |
% |
|
Non-GAAP income tax provision |
1.1 |
% |
|
1.2 |
% |
|
0.2 |
% |
|
|
|
|
|
|
|
|||
|
GAAP net loss |
(93.4 |
)% |
|
(42.7 |
)% |
|
(29.4 |
)% |
|
Total non-GAAP adjustments before income taxes |
65.8 |
% |
|
23.4 |
% |
|
32.1 |
% |
|
Less: total tax adjustments |
9.3 |
% |
|
3.5 |
% |
|
1.4 |
% |
|
Non-GAAP net income (loss) |
(37.0 |
)% |
|
(22.8 |
)% |
|
1.3 |
% |
|
UNAUDITED RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
|
|||||
|
|
|
|
|
||
|
|
Nine months ended |
||||
|
|
|
|
|
||
|
GAAP gross margin |
53.5 |
% |
|
55.8 |
% |
|
Stock-based compensation |
0.2 |
% |
|
0.1 |
% |
|
Performance based equity |
— |
% |
|
— |
% |
|
Amortization of purchased intangible assets |
6.3 |
% |
|
4.7 |
% |
|
Non-GAAP gross margin |
59.9 |
% |
|
60.7 |
% |
|
|
|
|
|
||
|
GAAP R&D expenses |
64.8 |
% |
|
36.0 |
% |
|
Stock-based compensation |
(10.4 |
)% |
|
(5.8 |
)% |
|
Performance based equity |
(0.9 |
)% |
|
(1.0 |
)% |
|
Research and development funded by others |
0.8 |
% |
|
(1.3 |
)% |
|
Non-GAAP R&D expenses |
54.3 |
% |
|
27.8 |
% |
|
|
|
|
|
||
|
GAAP SG&A expenses |
37.4 |
% |
|
17.2 |
% |
|
Stock-based compensation |
(7.0 |
)% |
|
(0.9 |
)% |
|
Performance based equity |
(0.5 |
)% |
|
(0.5 |
)% |
|
Amortization of purchased intangible assets |
(0.7 |
)% |
|
(0.4 |
)% |
|
Acquisition and integration costs |
(0.6 |
)% |
|
(1.3 |
)% |
|
Non-GAAP SG&A expenses |
28.6 |
% |
|
14.2 |
% |
|
|
|
|
|
||
|
GAAP impairment losses |
0.5 |
% |
|
0.4 |
% |
|
Impairment losses |
(0.5 |
)% |
|
(0.4 |
)% |
|
Non-GAAP impairment losses |
— |
% |
|
— |
% |
|
|
|
|
|
||
|
GAAP restructuring expenses |
18.8 |
% |
|
1.6 |
% |
|
Restructuring charges |
(18.8 |
)% |
|
(1.6 |
)% |
|
Non-GAAP restructuring expenses |
— |
% |
|
— |
% |
|
|
|
|
|
||
|
GAAP income (loss) from operations |
(67.9 |
)% |
|
0.6 |
% |
|
Total non-GAAP adjustments |
45.0 |
% |
|
18.1 |
% |
|
Non-GAAP income (loss) from operations |
(22.9 |
)% |
|
18.7 |
% |
|
|
|
|
|
||
|
GAAP interest and other income (expense), net |
(5.9 |
)% |
|
(4.4 |
)% |
|
Non-recurring interest and other income (expense), net |
4.4 |
% |
|
3.3 |
% |
|
Non-GAAP interest and other income (expense), net |
(1.4 |
)% |
|
(1.1 |
)% |
|
|
|
|
|
||
|
GAAP loss before income taxes |
(73.7 |
)% |
|
(3.7 |
)% |
|
Total non-GAAP adjustments |
49.4 |
% |
|
21.4 |
% |
|
Non-GAAP income (loss) before income taxes |
(24.4 |
)% |
|
17.6 |
% |
|
|
|
|
|
||
|
GAAP income tax provision (benefit) |
(3.9 |
)% |
|
2.4 |
% |
|
Adjustment for non-cash tax benefits/expenses |
5.0 |
% |
|
(0.6 |
)% |
|
Non-GAAP income tax provision |
1.1 |
% |
|
1.8 |
% |
|
|
|
|
|
||
|
GAAP net loss |
(69.8 |
)% |
|
(6.1 |
)% |
|
Total non-GAAP adjustments before income taxes |
49.4 |
% |
|
21.4 |
% |
|
Less: total tax adjustments |
5.0 |
% |
|
(0.6 |
)% |
|
Non-GAAP net income (loss) |
(25.5 |
)% |
|
15.9 |
% |
|
|
|
|
|
||
View source version on businesswire.com: https://www.businesswire.com/news/home/20241023178785/en/
Tel: +1 650-312-9060
lgreen@maxlinear.com
Source:
